AccuStem Sciences Limited
AccuStem Sciences Limited
Your view on ACMSY
Overview
What the company does, where it operates, and who runs it.
About AccuStem Sciences Limited
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Not available
- Headquarters
- 107 Cheapside, London, GB
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Not available
- Headquarters
- 107 Cheapside, London, GB
Accustem Sciences Limited engages in the genomic signature-based assay business for the prognosis of early and late recurrence of ER+/HER2 breast cancer in early stage breast cancer patients. The company was incorporated in 2020 and is based in London, the United Kingdom.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.